Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:59 pm Sale | 13G | Oyster Point Pharma Inc. OYST | Paradigm Biocapital Advisors LP | 0 0.000% | -1,462,576 (Position Closed) | View |
| 2023-02-14 4:08 pm Sale | 13G | Oyster Point Pharma Inc. OYST | Point72 Asset Management L.P. | 477 0.100% | -2,103,725 (-99.98%) | View |
| 2023-02-14 10:05 am Purchase | 13G | Oyster Point Pharma Inc. OYST | RTW INVESTMENTS LP | 2,304,977 8.600% | 246,473 (+11.97%) | View |
| 2023-01-13 4:09 pm Sale | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 0 0.000% | -2,236,888 (Position Closed) | View |
| 2023-01-09 4:32 pm Sale | 13D | Oyster Point Pharma Inc. OYST | New Enterprise Associates 14 L.P. | 0 0.000% | -5,925,287 (Position Closed) | View |
| 2023-01-05 4:32 pm Sale | 13D | Oyster Point Pharma Inc. OYST | InvOpps IV US L.P. | 0 0.000% | -2,768,586 (Position Closed) | View |
| 2022-12-20 5:41 pm Purchase | 13D | Oyster Point Pharma Inc. OYST | InvOpps IV US L.P. | 2,768,586 10.300% | 2,768,586 (New Position) | View |
| 2022-11-21 1:29 pm Unchanged | 13D | Oyster Point Pharma Inc. OYST | New Enterprise Associates 14 L.P. | 5,925,287 22.100% | 0 (Unchanged) | View |
| 2022-07-18 4:24 pm Purchase | 13G | Oyster Point Pharma Inc. OYST | Paradigm Biocapital Advisors LP | 1,462,576 5.500% | 1,462,576 (New Position) | View |
| 2022-02-14 4:44 pm Sale | 13G | Oyster Point Pharma Inc. OYST | Point72 Asset Management L.P. | 2,104,202 8.000% | -193,559 (-8.42%) | View |
| 2022-02-14 08:45 am Purchase | 13G | Oyster Point Pharma Inc. OYST | RTW INVESTMENTS LP | 2,058,504 7.900% | 132,910 (+6.90%) | View |
| 2022-02-04 09:22 am Sale | 13G | Oyster Point Pharma Inc. OYST | WELLINGTON MANAGEMENT GROUP LLP | 671,120 2.570% | -830,425 (-55.30%) | View |
| 2022-01-13 4:34 pm Unchanged | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 2,236,888 8.500% | 0 (Unchanged) | View |
| 2021-10-28 5:05 pm Purchase | 13G | Oyster Point Pharma Inc. OYST | Point72 Asset Management L.P. | 2,297,761 8.800% | 2,297,761 (New Position) | View |
| 2021-10-27 4:32 pm Unchanged | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 2,236,888 8.600% | 0 (Unchanged) | View |
| 2021-05-24 4:27 pm Unchanged | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 2,236,888 8.600% | 0 (Unchanged) | View |
| 2021-04-05 4:33 pm Unchanged | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 2,236,888 8.600% | 0 (Unchanged) | View |
| 2021-03-01 5:16 pm Sale | 13D | Oyster Point Pharma Inc. OYST | Versant Venture Capital VI L.P. | 2,236,888 8.600% | -325,000 (-12.69%) | View |
| 2021-02-12 09:30 am Purchase | 13G | Oyster Point Pharma Inc. OYST | RTW INVESTMENTS LP | 1,925,594 7.450% | 10,988 (+0.57%) | View |
| 2021-02-04 09:57 am Purchase | 13G | Oyster Point Pharma Inc. OYST | WELLINGTON MANAGEMENT GROUP LLP | 1,501,545 5.800% | 1,501,545 (New Position) | View |